The BioHub - by Avetix

Our little spin off of our time at JPM!Big announcements and exclusives! Here we have Angelos Stergiou, CEO of Sellas Life SciencesListen to hear how they've been doing.

Our little spin off of our time at JPM!Big announcements and exclusives! Here we have Michael Parini, CEO of Spur Therapeutics.Listen to hear how they've been doing.

Our little spin off of our time at JPM!Big announcements and exclusives! Here we have Yang Liu, CEO & CSO of OncoC4.Listen to hear how they've been doing.

The first of our little spin off and time at JPM!Big announcements and exclusives! Here we have Adrian Rawcliffe, CEO of Adaptimmune.Listen to hear how they've been doing.

Welcome to the BioHub podcast where we interview the top minds from across the Biotech and Pharma industry.We have a special guest—Michael Castagna, CEO of MannKind Corporation. Michael has over 25 years of experience in marketing, sales, and business development across both Fortune 500 companies and biotech startups.Under his leadership, MannKind has grown into a major player in the field of endocrine and orphan lung diseases, bringing innovative therapies like Afrezza®, the only inhaled ultra-rapid-acting insulin, to market.In this episode, Michael shares his journey, the challenges and triumphs of leading MannKind, and the future of the company’s groundbreaking technologies.We also dive deep into his passion for turning around struggling companies and the lessons he’s learned from navigating the biotech landscape.Enjoy and Stay Tuned.

Welcome to the BioHub podcast where we interview the top minds from across the Biotech and Pharma industry. We are thrilled to welcome Dr. Kevin Warner, Senior Vice President of Medical Affairs strategy and engagement at Heron Therapeutics. Dr. Warner brings 2 decades of experience in clinical and infusion pharmacy, with a special focus on pharmacokinetics, pharmacodynamics, and antimicrobial stewardship. He has been instrumental in co-developing the VT-X7 intra-articular antibiotic irrigation therapy and has played a crucial role in numerous committees dedicated to improving patient care.   At Heron Therapeutics, Dr. Warner is at the forefront of enhancing recovery after surgery and developing innovative pharmaceutical products using their proprietary Biochronomer™ drug delivery platform. With his extensive background and dedication to advancing patient care, Dr. Warner is a true leader in the pharmaceutical industry.   We’re excited to dive into his journey, explore Heron’s groundbreaking work, and discuss the future of pharmaceutical innovation. Enjoy and stay tuned.

Welcome to the BioHub podcast where we interview the top minds from across the Biotech and Pharma industry. We have Mark Mallon, CEO of George Medicines. Mark is a global leader in the pharmaceutical industry with over 25 years of experience. His career includes 24 years at AstraZeneca, where he held several key executive positions, leading operations across the globe. More recently, Mark has served as the CEO of NeoGenomics Laboratories and Ironwood Pharmaceuticals, driving transformation and growth in both roles. Now at George Medicines, Mark leads the development of innovative, combination therapies designed to optimize the treatment of cardiometabolic diseases. In this episode, we’ll explore Mark’s journey to George Medicines, the company’s innovative approach to tackling cardiometabolic diseases, and the importance of addressing global health inequities. Welcome to the show, Mark! Enjoy and stay tuned.

Welcome to the BioHub podcast where we interview the top minds from across the Biotech and Pharma industry. We are joined today by Founder and CEO of Terran Biosciences. Sam is a trailblazer in the Neuroscience space. We discuss a number of topics in this episode but have a lot of focus on recent FDA breakthroughs, upcoming plans with their lead drug TerXT.

Welcome to the BioHub podcast where we interview the top minds from across the Biotech and Pharma industry. We're joined by CEO and Founder, Jason Bock. Jason has been instrumental in the mAb space, and now making a move into the CAR-T space. In this episode, Jason shares his career experience, the move from mAb to CAR-T, and how CTMC is playing their part in this.

Welcome to the BioHub podcast where we interview the top minds from across the Biotech and Pharma industry. We’re joined by Joe Payne, CEO and founder of Arcturus Therapeutics. Joe has been instrumental in pushing the boundaries of mRNA technology, leading Arcturus to develop one of the first self-amplifying mRNA COVID-19 vaccines and pioneering new treatments for diseases like cystic fibrosis. In this episode, Joe shares his journey, the ground breaking work at Arcturus, and his vision for the future of RNA medicine. Let’s dive in! Enjoy and stay tuned.